AACR: More Cancer Patients Benefiting From Immunotherapy

Share this content:
AACR: More Cancer Patients Benefiting From Immunotherapy
AACR: More Cancer Patients Benefiting From Immunotherapy

WEDNESDAY, Sept. 21, 2016 (HealthDay News) -- More Americans are benefiting from immunotherapy, according to the sixth annual American Association for Cancer Research (AACR) Cancer Progress Report.

More types of cancer are being successfully treated with immunotherapy. "The promise of immunotherapy for cancer therapy has never been greater, and the opportunity to make significant progress in this critical area is real," Nancy Davidson, M.D., president of AACR, said in an association news release.

In August 2015, checkpoint inhibitors were approved for just melanoma and lung cancer. About a year later, these drugs were subsequently approved for four more types of cancer, including bladder cancer, head and neck cancer, Hodgkin's lymphoma, and kidney cancer.

Immunotherapy drugs account for four of the 13 new anticancer treatments approved over the past year, the AACR report showed. New uses have also been found for 11 previously approved anticancer drugs. A new cancer screening test, two new imaging agents to help diagnose cancer, and a new medical device have all been approved by the U.S. Food and Drug Administration, the AACR noted.

More Information

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »


Sign up for myCME e-newsletters


Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions

More in Home

FDA Approves Bavencio for Merkel Cell Carcinoma

FDA Approves Bavencio for Merkel Cell Carcinoma

Drug targets the PD-1/PD-L1 pathway; first sanctioned treatment in the United States

Heterogeneous Association for Alcohol, CVD Presentation

Heterogeneous Association for Alcohol, CVD Presentation

Non-drinking linked to increased risks of unstable angina, MI, heart failure, ischemic stroke, PAD, AAA

Mobile App Cuts In-Person Visits After Breast Reconstruction

Mobile App Cuts In-Person Visits After Breast Reconstruction

Number of visits down, increase in e-mails to doctors for ambulatory patients undergoing breast recon

is free, fast, and customized just for you!

Already a member?

Sign In Now »